ACC.26 Día 3 (Parte 2)
En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este tercer día en el ACC 2026 de Nueva Orleans. 1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial 2. The Heartline Experience: Achieving Long-Term Participant Engagement in Digital Health Technology Trials 3. Effect Of Anti-fibrotic Therapy On Regression Of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) In Aortic Stenosis Patients With High Fibrotic Burden: The Reduce-MFA DZHK 25-trial
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of CARDIOSÍNTESIS PODCAST?
This episode is 27 minutes long.
When was this CARDIOSÍNTESIS PODCAST episode published?
This episode was published on April 1, 2026.
Can I download this CARDIOSÍNTESIS PODCAST episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.